Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory Syndrome-Reference-Cited by-同舟云学术

Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome

Published:2023-06-15 Issue:24 Volume:388 Page:2241-2252
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Baghdassarian Hratch¹,Blackstone Sarah A.¹,Clay Owen S.¹^ORCID,Philips Rachael¹,Matthiasardottir Brynja¹,Nehrebecky Michele¹,Hua Vivian K.¹,McVicar Rachael¹,Liu Yang¹,Tucker Suzanne M.¹,Randazzo Davide¹^ORCID,Deuitch Natalie¹^ORCID,Rosenzweig Sofia¹^ORCID,Mark Adam¹,Sasik Roman¹,Fisch Kathleen M.¹,Pimpale Chavan Pallavi¹^ORCID,Eren Elif¹,Watts Norman R.¹,Ma Chi A.¹,Gadina Massimo¹,Schwartz Daniella M.¹,Sanyal Anwesha¹,Werner Giffin¹,Murdock David R.¹,Horita Nobuyuki¹,Chowdhury Shimul¹,Dimmock David¹,Jepsen Kristen¹,Remmers Elaine F.¹,Goldbach-Mansky Raphaela¹,Gahl William A.¹,O’Shea John J.¹,Milner Joshua D.¹,Lewis Nathan E.¹,Chang Johanna¹,Kastner Daniel L.¹,Torok Kathryn¹,Oda Hirotsugu¹,Putnam Christopher D.¹,Broderick Lori¹

Affiliation:

1. From the Bioinformatics and Systems Biology Program (H.B.), the Department of Pediatrics (H.B., O.S.C., V.K.H., N.E.L.), the Center for Computational Biology and Bioinformatics, Department of Medicine (A.M., R.S., K.M.F.), the Institute for Genomic Medicine (K.J.), the Department of Bioengineering (N.E.L.), the Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics (J.C., L.B.), and the Department of Medicine (C.D.P.), University of California, San Diego, Sanford Burnham Prebys...

Funder

Collaborative Research Center

American Academy of Allergy, Asthma and Immunology Foundation

Ludwig Institute for Cancer Research

National Institutes of Health

Novo Nordisk Fonden

California Institute for Regenerative Medicine

Hydrocephalus Association

Scleroderma Research Foundation

Deutsche Forschungsgemeinschaft

Publisher

Massachusetts Medical Society